Global NGS Sequencers Market Growth 2023-2029
The global NGS Sequencers market size is projected to grow from US$ 857.9 million in 2022 to US$ 2513.5 million in 2029; it is expected to grow at a CAGR of 16.6% from 2023 to 2029.
United States market for NGS Sequencers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for NGS Sequencers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for NGS Sequencers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key NGS Sequencers players cover Illumina Inc., BioMérieux, Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, BGI, PacBio, Agilent Technologies and Gene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
NGS sequencer is a massively parallel sequencing technology that can perform sequencing with ultra-high throughput, ultra-strong scalability, and ultra-fast speed. This technique is used to determine the order of nucleotides throughout the genome or in targeted regions of DNA or RNA.
LPI (LP Information)' newest research report, the “NGS Sequencers Industry Forecast” looks at past sales and reviews total world NGS Sequencers sales in 2022, providing a comprehensive analysis by region and market sector of projected NGS Sequencers sales for 2023 through 2029. With NGS Sequencers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NGS Sequencers industry.
This Insight Report provides a comprehensive analysis of the global NGS Sequencers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NGS Sequencers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global NGS Sequencers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NGS Sequencers and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NGS Sequencers.
This report presents a comprehensive overview, market shares, and growth opportunities of NGS Sequencers market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing
Segmentation by application
Hospitals and Clinics
Academic and Research Institutions
Pharmaceutical and Biotech Companies
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina Inc.
BioMérieux
Life Technologies Corporation
Thermo Fisher Scientific
Memorial Sloan Kettering
BGI
PacBio
Agilent Technologies
Gene
Roche
Beckman Coulter
PerkinElmer
GTH.O
Boao Bio Group
Oxford Nanopore Technologies
Key Questions Addressed in this Report
What is the 10-year outlook for the global NGS Sequencers market?
What factors are driving NGS Sequencers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do NGS Sequencers market opportunities vary by end market size?
How does NGS Sequencers break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.